<DOC>
	<DOC>NCT02803268</DOC>
	<brief_summary>A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms</brief_summary>
	<brief_title>A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms</brief_title>
	<detailed_description />
	<criteria>Subjects must meet one of the following criteria:Woman aged ≥18 years with histologically proven nonmetastatic breast cancer (Stages I, II or III) and without evidence of disease / Woman aged ≥40 years who are postmenopausal / Woman aged ≥40 years who are perimenopausal Subjects who have ≥7 Vasomotor Symptoms per day on average A body weight of ≥45 kg Participation in more than three clinical studies involving administration of an unlicensed Investigational Medicinal Product in the previous year, or any study within 12 weeks Clinically significant endocrine, thyroid, hepatic, respiratory, gastrointestinal, renal, cardiovascular disease, or history of any significant psychiatric/psychotic illness disorder Clinically relevant abnormal medical history, physical findings or laboratory values</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>